Fructose as a key player in the development of fatty liver disease

World Journal of Gastroenterology

Volumn 19, Issue 8, 2013, Pages 1166-1172

  Basaranoglu, Metin ^a   Basaranoglu, Gokcen ^a   Sabuncu, Tevfik ^b   Sentürk, Hakan ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Cytokines; Diabetes; Fatty liver; Fructose; Insulin resistance; Nonalcoholic; Obesity

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADIPONECTIN; CHOLESTEROL; FRUCTOSE; I KAPPA B KINASE BETA; INSULIN; INTERLEUKIN 6; LEPTIN; PROTEIN KINASE C; STAT PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CHRONIC LIVER DISEASE; DIET; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; FAST FOOD; FATTY LIVER; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; LIVER FIBROSIS; LIVER METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PHOSPHORYLATION; PREVALENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84874618646     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i8.1166     Document Type: Article

References (59)

1. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419 [PMID: 10348825]
2. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-455 [PMID: 10569299 DOI: 10.1016/S0002-9343(99)00271-5]
3. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850 [PMID: 11473047 DOI: 10.2337/diabetes.50.8.1844]
4. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-3028 [PMID: 12107194 DOI: 10.1210/jc.87.7.3023]
5. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35: 367-372 [PMID: 11826410 DOI: 10.1053/jhep.2002.30690]
6. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923 [PMID: 12668987 DOI: 10.1053/jhep.2003.50161]
7. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669 [PMID: 10051466 DOI: 10.1002/ hep.510290347]
8. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a casecontrol study. Hepatology 2000; 32: 689-692 [PMID: 11003611 DOI: 10.1053/jhep.2000.17894]
9. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001; 7: 608-614 [PMID: 11460228 DOI: 10.1053/jlts.2001.25453]
10. Keaney JF, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23: 434-439 [PMID: 12615693]
11. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a highfructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008; 295: G987-G995 [PMID: 18772365 DOI: 10.1152/ajpgi. 90272.2008]
12. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002; 76: 911-922 [PMID: 12399260]
13. James J, Thomas P, Cavan D, Kerr D. Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. BMJ 2004; 328: 1237 [PMID: 15107313]
14. Teff KL, Elliott SS, Tschöp M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 2004; 89: 2963-2972 [PMID: 15181085]
15. Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005; 54: 1907-1913 [PMID: 15983189]
16. Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D'Agostino RB, Gaziano JM, Vasan RS. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middleaged adults in the community. Circulation 2007; 116: 480-488 [PMID: 17646581]
17. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808 [PMID: 14679176]
18. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J Clin Invest 2003; 112: 1821-1830 [PMID: 14679177]
19. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense highdensity lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004; 89: 4963-4971 [PMID: 15472192]
20. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761 [PMID: 15599400]
21. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, Giral P, Grimaldi A, Opolon P, Poynard T. Survival, liver failure, and hepatocellular carcinoma in obesityrelated cryptogenic cirrhosis. Hepatology 2002; 35: 1485-1493 [PMID: 12029634 DOI: 10.1053/jhep.2002.33324]
22. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117-1123 [PMID: 10833486]
23. Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab 2004; 89: 2522-2525 [PMID: 15181019]
24. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI. Mechanism by which highdose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002; 109: 1321-1326 [PMID: 12021247]
25. Seki S, Kitada T, Sakaguchi H. Clinicopathological significance of oxidative cellular damage in nonalcoholic fatty liver diseases. Hepatol Res 2005; 33: 132-134 [PMID: 16198621]
26. Marchesini G, Ridolfi V, Nepoti V. Hepatotoxicity of fast food? Gut 2008; 57: 568-570 [PMID: 18408097 DOI: 10.1136/ gut.2007.143958]
27. Milagro FI, Campión J, Martínez JA. Weight gain induced by highfat feeding involves increased liver oxidative stress. Obesity (Silver Spring) 2006; 14: 1118-1123 [PMID: 16899792 DOI: 10.1038/oby.2006.128]
28. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med 2006; 354: 1601-1613 [PMID: 16611951 DOI: 10.1056/ NEJMra054035]
29. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004; 40: 185-194 [PMID: 15239102 DOI: 10.1002/hep.20283]
30. Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin Liver Dis 2004; 8: 639-671 [PMID: 15331068]
31. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119 [PMID: 15864338]
32. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-1219 [PMID: 12717402]
33. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1343-1351 [PMID: 15864352]
34. Tamura S, Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1139-1142 [PMID: 15864343]
35. Neuschwander-Tetri BA, Ford DA, Acharya S, Gilkey G, Basaranoglu M, Tetri LH, Brunt EM. Dietary transfatty acid induced NASH is normalized following loss of transfatty acids from hepatic lipid pools. Lipids 2012; 47: 941-950 [PMID: 22923371]
36. 2-dependent repression of hepatic lipolysis, β-oxidation and VLDL-synthesis. Lab Invest 2012; 92: 1597-1606 [PMID: 22964849 DOI: 10.1038/labinvest. 2012.128]
37. Arai T, Kim HJ, Hirako S, Nakasatomi M, Chiba H, Matsumoto A. Effects of dietary fat energy restriction and fish oil feeding on hepatic metabolic abnormalities and insulin resistance in KK mice with highfat dietinduced obesity. J Nutr Biochem 2013; 24: 267-273 [PMID: 22901684]
38. Flannery C, Dufour S, Rabøl R, Shulman GI, Petersen KF. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes 2012; 61: 2711-2717 [PMID: 22829450]
39. Tappy L, Lê KA. Does fructose consumption contribute to nonalcoholic fatty liver disease? Clin Res Hepatol Gastroenterol 2012; 36: 554-560 [PMID: 22795319]
40. Sashidhara KV, Kumar M, Sonkar R, Singh BS, Khanna AK, Bhatia G. Indolebased fibrates as potential hypolipidemic and antiobesity agents. J Med Chem 2012; 55: 2769-2779 [PMID: 22339404]
41. Kok BP, Kienesberger PC, Dyck JR, Brindley DN. Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice. J Lipid Res 2012; 53: 105-118 [PMID: 22058427]
42. Herrema H, Meissner M, van Dijk TH, Brufau G, Boverhof R, Oosterveer MH, Reijngoud DJ, Müller M, Stellaard F, Groen AK, Kuipers F. Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor-and liver X receptor alphacontrolled metabolic pathways in mice. Hepatology 2010; 51: 806-816 [PMID: 19998408]
43. Sevastianova K, Santos A, Kotronen A, Hakkarainen A, Makkonen J, Silander K, Peltonen M, Romeo S, Lundbom J, Lundbom N, Olkkonen VM, Gylling H, Fielding BA, Rissanen A, Yki-Järvinen H. Effect of shortterm carbohydrate overfeeding and longterm weight loss on liver fat in overweight humans. Am J Clin Nutr 2012; 96: 727-734 [PMID: 22952180]
44. Carvalhana S, Machado MV, Cortez-Pinto H. Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2012; 15: 468-473 [PMID: 22878240]
45. Tsuchiya H, Ebata Y, Sakabe T, Hama S, Kogure K, Shiota G. Highfat, highfructose diet induces hepatic iron overload via a hepcidinindependent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism 2013; 62: 62-69 [PMID: 22854109]
46. Utzschneider KM, Bayer-Carter JL, Arbuckle MD, Tidwell JM, Richards TL, Craft S. Beneficial effect of a weightstable, lowfat/lowsaturated fat/lowglycaemic index diet to reduce liver fat in older subjects. Br J Nutr 2012; 1-9 [PMID: 22849970]
47. Johnson RJ, Lanaspa MA, Roncal-Jimenez C, Sanchez-Lozada LG. Effects of excessive fructose intake on health. Ann Intern Med 2012; 156: 905; author reply 905-906 [PMID: 22711095]
48. Li M, Feng F, Cheng L. Expression patterns of genes involved in sugar metabolism and accumulation during apple fruit development. PLoS One 2012; 7: e33055 [PMID: 22412983]
49. Mellouk Z, Zhang Y, Bulur N, Louchami K, Sener A, Ait Yahia D, Malaisse WJ. The metabolic syndrome of fructosefed rats: effects of longchain polyunsaturated ω3 and ω6 fatty acids. IV. D-glucose metabolism by isolated pancreatic islets. Int J Mol Med 2012; 29: 291-293 [PMID: 22076599 DOI: 10.3892/ijmm.2011.824]
50. Liu J, Litt L, Segal MR, Kelly MJ, Pelton JG, Kim M. Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolites. Int J Mol Sci 2011; 12: 6469-6501 [PMID: 22072900]
51. Bray GA. Fructose and risk of cardiometabolic disease. Curr Atheroscler Rep 2012; 14: 570-578 [PMID: 22949106]
52. Caporaso N, Morisco F, Camera S, Graziani G, Donnarumma L, Ritieni A. Dietary approach in the prevention and treatment of NAFLD. Front Biosci 2012; 17: 2259-2268 [PMID: 22652776]
53. Zelber-Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011; 17: 3377-3389 [PMID: 21876630]
54. Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 2579-2588 [PMID: 20518077]
55. Alegret M, Laguna JC. Opposite fates of fructose in the development of metabolic syndrome. World J Gastroenterol 2012; 18: 4478-4480 [PMID: 22969219]
56. Sahebkar A. Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. World J Gastroenterol 2011; 17: 271-272 [PMID: 21246004]
57. Mathes AM. Hepatoprotective actions of melatonin: possible mediation by melatonin receptors. World J Gastroenterol 2010; 16: 6087-6097 [PMID: 21182223]
58. Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 2010; 16: 6035-6043 [PMID: 21182217]
59. Grattagliano I, Bonfrate L, Diogo CV, Wang HH, Wang DQ, Portincasa P. Biochemical mechanisms in druginduced liver injury: certainties and doubts. World J Gastroenterol 2009; 15: 4865-4876 [PMID: 19842215]